The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Hall, S. M.
* Articles by Cullen, J.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Hall, S. M.
* Articles by Cullen, J.
Related Collections
* Nicotine
* Other Psychotherapy
* Antidepressants
*Related Article
Am J Psychiatry 161:2100-2107, November 2004
© 2004 American Psychiatric Association

Extended Nortriptyline and Psychological Treatment for Cigarette Smoking

Sharon M. Hall, Ph.D., Gary L. Humfleet, Ph.D., Victor I. Reus, M.D., Ricardo F. Muñoz, Ph.D., and Jennifer Cullen, Ph.D.

OBJECTIVE: Accepted treatments for cigarette smoking rarely achieve abstinence rates of >35% at 1 year. Low rates may reflect failure to provide extended and multifocal treatment for this complex and chronic addiction. Using a chronic disease model of smoking, the authors undertook a study to determine the effects of long-term antidepressant and psychological treatment. METHOD: One hundred sixty smokers of ≥10 cigarettes/day were randomly assigned to one of four treatment conditions in a two-by-two (nortriptyline versus placebo by brief versus extended treatment) design. All subjects received 8 weeks of a transdermal nicotine patch, five group counseling sessions, and active or placebo treatment. Interventions for subjects in brief treatment ended at this point. Subjects in extended treatment continued taking drug or placebo to week 52 and received an additional 9 monthly counseling sessions, with checkup telephone calls midway through each session. Subjects were assessed at baseline and weeks 12, 24, 36, and 52. The principal outcome variables were repeated abstinence at each assessment after the first over a 1-year period and a point prevalence of 7 days of abstinence. RESULTS: At week 52, point-prevalence abstinence rates with missing subjects imputed as smokers were 30% for placebo brief treatment, 42% for placebo extended treatment, 18% for active brief treatment, and 50% for active extended treatment. With missing subjects omitted, these rates were 32%, 57%, 21%, and 56%, respectively. CONCLUSIONS: Comprehensive extended treatments that combine drug and psychological interventions can produce consistent abstinence rates that are substantially higher than those in the literature.


Related Article:

In This Issue
Am J Psychiatry 2004 161: A62. [Full Text] [PDF]



This article has been cited by other articles:


Home page
Nicotine Tob ResHome page
E. N. Peters and J. R. Hughes
The day-to-day process of stopping or reducing smoking: A prospective study of self-changers
Nicotine Tob Res, September 1, 2009; 11(9): 1083 - 1092.
[Abstract] [Full Text] [PDF]


Home page
Nicotine Tob ResHome page
R. F. Munoz, A. Z. Barrera, K. Delucchi, C. Penilla, L. D. Torres, and E. J. Perez-Stable
International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year
Nicotine Tob Res, September 1, 2009; 11(9): 1025 - 1034.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
R Ray, M Rukstalis, C Jepson, A. Strasser, F Patterson, K Lynch, and C Lerman
Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence
J Psychopharmacol, March 1, 2009; 23(2): 168 - 176.
[Abstract] [PDF]


Home page
JAMAHome page
S. A. Schroeder
A 51-Year-Old Woman With Bipolar Disorder Who Wants to Quit Smoking
JAMA, February 4, 2009; 301(5): 522 - 531.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P. Aveyard, C. Johnson, S. Fillingham, A. Parsons, and M. Murphy
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial
BMJ, May 31, 2008; 336(7655): 1223 - 1227.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. P David and M. R Munafo
Smoking cessation in primary care
BMJ, May 31, 2008; 336(7655): 1200 - 1201.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. Ranney, C. Melvin, L. Lux, E. McClain, and K. N. Lohr
Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations
Ann Intern Med, December 5, 2006; 145(11): 845 - 856.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. P. L. Sachs
Tobacco dependence treatment: time to change the paradigm.
Chest, April 1, 2006; 129(4): 836 - 839.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
J. E. Henningfield, R. V. Fant, A. R. Buchhalter, and M. L. Stitzer
Pharmacotherapy for Nicotine Dependence
CA Cancer J Clin, September 1, 2005; 55(5): 281 - 299.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. McFall, A. J. Saxon, C. E. Thompson, D. Yoshimoto, C. Malte, K. Straits-Troster, E. Kanter, X.-H. A. Zhou, C. M. Dougherty, and B. Steele
Improving the Rates of Quitting Smoking for Veterans With Posttraumatic Stress Disorder
Am J Psychiatry, July 1, 2005; 162(7): 1311 - 1319.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Med.Home page
Other articles noted
Evid. Based Med., June 1, 2005; 10(3): 95 - 96.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org